Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000517992 | SCV000614625 | uncertain significance | not specified | 2017-04-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001722437 | SCV000730764 | likely benign | not provided | 2019-05-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000876023 | SCV001018528 | likely benign | Epidermolysis bullosa simplex 5B, with muscular dystrophy; Epidermolysis bullosa simplex, Ogna type; Epidermolysis bullosa simplex 5C, with pyloric atresia; Autosomal recessive limb-girdle muscular dystrophy type 2Q; Epidermolysis bullosa simplex with nail dystrophy | 2025-01-06 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001722437 | SCV003811166 | uncertain significance | not provided | 2021-09-23 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004541613 | SCV004768772 | likely benign | PLEC-related disorder | 2021-11-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |